Arena Pharma (ARNA) Misses Q3 EPS by 68c
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Financial Fact:
General and administrative: 8.59M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
General and administrative: 8.59M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Arena Pharma (NASDAQ: ARNA) reported Q3 EPS of ($3.21), $0.68 worse than the analyst estimate of ($2.53). Revenue for the quarter came in at $0 versus the consensus estimate of $680 thousand.
For earnings history and earnings-related data on Arena Pharma (ARNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Beam Global (BEEM) Tops Q2 EPS by 8c
- Unifi, Inc. (UFI) Misses Q4 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
